Fingerprint
Dive into the research topics of 'A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer
Jennifer M. Segar, Darien Reed, Alison Stopeck, Robert B. Livingston, Pavani Chalasani
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations